Induction of multiple myeloma-reactive T cells during post-transplantation immunotherapy with donor lymphocytes and recipient DCs.
about
Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.A phase I/II minor histocompatibility antigen-loaded dendritic cell vaccination trial to safely improve the efficacy of donor lymphocyte infusions in myeloma.CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
P2860
Induction of multiple myeloma-reactive T cells during post-transplantation immunotherapy with donor lymphocytes and recipient DCs.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Induction of multiple myeloma- ...... lymphocytes and recipient DCs.
@en
Induction of multiple myeloma- ...... lymphocytes and recipient DCs.
@nl
type
label
Induction of multiple myeloma- ...... lymphocytes and recipient DCs.
@en
Induction of multiple myeloma- ...... lymphocytes and recipient DCs.
@nl
prefLabel
Induction of multiple myeloma- ...... lymphocytes and recipient DCs.
@en
Induction of multiple myeloma- ...... lymphocytes and recipient DCs.
@nl
P2093
P2860
P356
P1476
Induction of multiple myeloma- ...... lymphocytes and recipient DCs
@en
P2093
A Greupink-Draaisma
P2860
P2888
P304
P356
10.1038/BMT.2011.258
P407
P577
2012-01-16T00:00:00Z